论著

上海市松江地区2016年到2017年52 973例妇科门诊患者人乳头瘤病毒亚型感染情况分析

展开
  • 1.上海市松江区九亭医院检验科, 上海 2016152
    2.上海市松江区中心医院检验科,上海201600

收稿日期: 2019-06-01

  网络出版日期: 2019-08-25

基金资助

上海市松江区科学技术攻关项目(16SJGG45)

Study on human papillomavirus infection in gynecological outpatients in Songjiang District during 2016 to 2017

Expand
  • 1. Department of Laboratory, Jiu Ting Hospital of Songjiang District, Shanghai 201615, China
    2. Department of Laboratory,Central Hospital of Songjiang District,Shanghai 201600, China

Received date: 2019-06-01

  Online published: 2019-08-25

摘要

目的: 分析上海市松江地区女性人乳头瘤病毒(human papillomavirus, HPV)感染及其亚型分布的情况,为预防HPV感染提供理论依据。方法: 本研究使用基因芯片检测技术,对52 973例妇科门诊患者进行HPV亚型检测。结果: 结果提示共计12 139例患者感染HPV,感染率为22.92%,共检出HPV 16 637株,其中高危型HPV占78.61%。感染率最高的5种HPV亚型依次为16、58、52、51、68型,均为高危型。单一亚型病毒感染的患者有8 933例,占总HPV感染者的73.50%,单一亚型感染者中又以高危亚型感染为主(占80.48%);多重亚型感染者共有3 206例(26.50%),其中以二重感染为主,而二重感染患者又以单纯高危型感染为主(占57.71%),常见的感染亚型组合为HPV16型和58型。≤20岁、21~30岁、31~40岁、41~50岁、51~60岁、≥61岁年龄组的HPV感染率分别为31.83%、21.48%、20.66%、23.69%、30.35%、33.88%。结论: 松江地区妇科门诊患者的HPV总感染率为22.92%,其中最常见的HPV亚型为16、58、52、51、68型,患者以单一亚型感染为主,以高危亚型常见,而发生二重感染的患者以单纯高危亚型感染多见,60岁以上的妇科门诊患者的HPV感染率较高。

本文引用格式

王宏, 黄路遥, 杨翌翔 . 上海市松江地区2016年到2017年52 973例妇科门诊患者人乳头瘤病毒亚型感染情况分析[J]. 诊断学理论与实践, 2019 , 18(04) : 460 -465 . DOI: 10.16150/j.1671-2870.2019.04.015

Abstract

Objective: To analyze the distribution of human papilloma virus (HPV) infection and subtypes in Songjiang District, Shanghai for providing a theoretical basis for prevention of HPV infection. Method: A total of 52 973 gynecological outpatients tested for HPV subtypes by gene chip detection were enrolled in this study. Result: A total of 12 139 patients were infected with HPV. The HBV infection rate was 22.92%. Altogether 16 637 strains of human papilloma virus were detected, and high-risk HPV subtypes accounted for 78.61%. The top five infection subtypes were: HPV16, 58, 52, 51, 68, all of which were high-risk subtypes. Of the infected patients, 8 933 cases were single infection (73.50%), mainly with high-risk subtypes, accounting for 80.48%; 3 206 cases were multiple infection (26.50%), most of which were double infection with high-risk subtype (57.71%), and the common ones were HPV16 and 58. The infection rates of ≤20 years old, 21-30 years old, 31-40 years old, 41-50 years old, 51-60 years old, ≥61 years old groups were 31.83%, 21.48%, 20.66%, 23.69%, 30.35%, 33.88%, respectively. Conclusions: In Songjiang District, HPV infection rate among gynecological outpatients was 22.92%. The most common HPV subtypes were 16, 58, 52, 51, 68. The majority is single infection, and most of which with high-risk subtypes. Among double infection, most were high-risk subtype combination. The age group ≥60 years shows higher infection rate.

参考文献

[1] Vaezi T, Shoja Z, Hamkar R, et al. Human papillomavirus type 16 lineage analysis based on E6 region in cervical samples of Iranian women[J]. Infect Genet Evol, 2017, 55:26-30.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3] Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907.
[4] Zandberg DP, Bhargava R, Badin S, et al. The role of human papillomavirus in nongenital cancers[J]. CA Cancer J Clin, 2013, 63(1):57-81.
[5] Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping[J]. J Gynecol Oncol, 2016, 27(2):e21.
[6] 王蕾, 董志玲, 张利宾, 等. 邯郸地区10 306例妇科门诊女性患者HPV基因分型及感染特征分析[J]. 医学综述, 2019, 25(6):1245-1248.
[7] 杨阳, 陈良远, 曹鹏驹, 等. 福州地区体检女性HPV感染及基因亚型分析[J]. 检验医学, 2019, 34(2):144-147.
[8] 温旺荣, 李莉. HPV 基因检测技术新进展[J]. 中华检验医学杂志, 2015, 38(8):514-516.
[9] 许惠惠, 石卫武, 徐玖飞, 等. HPV 基因分型在宫颈癌筛查风险分层管理中的价值[J]. 中华实验和临床病毒学杂志, 2016, 30(1):14-18.
[10] 单玮, 张涛, 张铁军, 等. 我国女性人乳头瘤病毒(HPV)感染的流行病学现状[J]. 中华疾病控制杂志, 2017, 21(1):89-93.
[11] 李栋立, 秦基取, 钱福初, 等. 浙江省湖州地区10 680例女性人乳头瘤病毒感染及基因分型分析[J]. 疾病监测, 2015, 30(3):209-213.
[12] 冀静, 张海满, 李娜, 等. 西安地区门诊机会筛查妇女HPV感染状况分析[J]. 海南医学, 2017, 28(18):3004-3006.
[13] 许维东, 李月, 滕贤麟, 等. 浙江省金华市人民医院妇科门诊女性感染宫颈上皮细胞人乳头瘤病毒亚型分布特征分析[J]. 中国基层医药, 2017, 24(8):1225-1228.
[14] Wen Z, Lei Z, Jin-An M, et al. The inhibitory role of miR-214 in cervical cancer cells through directly targe-ting mitochondrial transcription factor A (TFAM)[J]. Eur J Gynaecol Oncol, 2014, 35(6):676-682.
[15] Singh S, Zhou Q, Yu Y, et al. Distribution of HPV genotypes in Shanghai women[J]. Int J Clin Exp Pathol, 2015, 8(9):11901-11908.
[16] 吴翠霞, 张艳红, 葛小花, 等. 高危型HPV感染与宫颈癌前病变与宫颈癌的相关性研究[J]. 中华医院感染学杂志, 2016, 26(11):2568-2570.
[17] de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010, 11(11):1048-1056.
[18] Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial[J]. Lancet Oncol, 2012, 13(1):89-99.
[19] 缪应新, 甘洁民, 陈洁, 等. 上海地区人乳头瘤病毒基因芯片法分型检测的临床意义[J]. 检验医学, 2015, 30(6):595-598.
文章导航

/